Menu
Our services include AI-based toxicity prediction, real-time data analytics and reporting, and population-specific risk assessment, helping to enhance safety, optimize decision-making, and provide targeted solutions for diverse healthcare needs.
Our AI-driven predictive toxicology service provides detailed toxicity prediction reports for drug candidates. Utilizing advanced machine learning models and extensive datasets, we deliver comprehensive insights into potential safety risks. These reports enable pharmaceutical companies to make data-informed decisions, mitigate late-stage failures, and streamline the drug development process with confidence.
Our iPSC (induced pluripotent stem cell)-based toxicity testing service provides human-relevant, population-specific insights into drug safety. By mimicking diverse human genetic and physiological conditions, this cutting-edge approach ensures accurate assessment of potential toxicities. This service reduces reliance on animal models and supports precision medicine by identifying safety risks tailored to specific patient populations.
Empower your team with cutting-edge AI models, trained on diverse human-relevant data, to guide each stage of drug discovery with precision. With flexible subscription and pay-as-you-go options, Biolligence makes advanced toxicity prediction accessible and scalable, adapting to your project’s unique needs.